Corcept Therapeutics Inc
XMUN:HTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corcept Therapeutics Inc
XMUN:HTD
|
US |
|
S
|
Societe BIC SA
XMUN:BIF
|
FR |
|
W
|
Workpoint Entertainment PCL
SET:WORK
|
TH |
|
Cidara Therapeutics Inc
NASDAQ:CDTX
|
US |
|
Lucid Group Inc
F:CH2
|
US |
|
A
|
Almonty Industries Inc
F:ALI
|
CA |
|
Lagardere SA
PAR:MMB
|
FR |
|
C
|
Canon Marketing Japan Inc
F:CNJ
|
JP |
|
B
|
Becton Dickinson and Co
SWB:BOX
|
US |
|
J
|
Julius Baer Gruppe AG
F:JGE
|
CH |
|
B
|
Becton Dickinson and Co
DUS:BOX
|
US |
|
Murata Manufacturing Co Ltd
F:MUR
|
JP |
|
E
|
Euronet Worldwide Inc
SWB:EEF
|
US |
|
C
|
Cal-Maine Foods Inc
F:CM2
|
US |
Wall St Price Targets
HTD Price Targets Summary
Corcept Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for HTD is 76.3 EUR with a low forecast of 42.93 EUR and a high forecast of 120.49 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HTD's stock price target?
Price Target
76.3
EUR
According to Wall Street analysts, the average 1-year price target for HTD is 76.3 EUR with a low forecast of 42.93 EUR and a high forecast of 120.49 EUR.
What is the Revenue forecast for Corcept Therapeutics Inc?
Projected CAGR
32%
Over the last 13 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 3 years is 32%.
What is the Gross Profit forecast for Corcept Therapeutics Inc?
Projected CAGR
32%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 52%. The projected CAGR for the next 3 years is 32%.
What is the Operating Income forecast for Corcept Therapeutics Inc?
Projected CAGR
148%
The compound annual growth rate for Operating Income over the next 3 years is 148%.
What is the Pre-Tax Income forecast for Corcept Therapeutics Inc?
Projected CAGR
108%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 108%.
What is the Net Income forecast for Corcept Therapeutics Inc?
Projected CAGR
68%
The compound annual growth rate for Net Income over the next 3 years is 68%.
